Human Leukocyte Antigen Antibodies (HLA-Ab) generated by transplant patients are the primary cause of chronic allograft rejection. B-cell activating factor in serum (sBAFF) is a B-cell differentiation and maturation cytokine that might be a biomarker for HLA-Ab production. A new sBAFF detection assay was developed and used to test a total of 139 serum samples from 17 non-sensitized male, 18 transfusion, and 21 kidney transplant patients. sBAFF was correlated with HLA-Ab production; non-sensitized males with low HLA-Ab had an average sBAFF level of 48,441 pg/mL versus 183,975 pg/mL for highly-sensitized transfusion patients (p<0.0001). Temporal analysis between sBAFF and HLA-Ab supports a lag effect where a rise in sBAFF precedes a rise in average HLA-Ab by 10 days and a rise in donor-specific HLA antibody by 19 days. Our findings suggest that sBAFF levels may be predictive of imminent HLA-Ab production and may facilitate earlier and more effective treatment of HLA-Ab.
|Advisor:||Terasaki, Paul I.|
|School:||California State University, Dominguez Hills|
|School Location:||United States -- California|
|Source:||MAI 49/04M, Masters Abstracts International|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
supplemental files is subject to the ProQuest Terms and Conditions of use.